Anti-HIV drug combination that should not be used
**Core Concept**
The question requires knowledge of antiretroviral therapy (ART) for HIV management, specifically the combination of drugs that should be avoided due to adverse interactions or increased toxicity.
**Why the Correct Answer is Right**
Combining certain antiretroviral drugs can lead to increased toxicity, reduced efficacy, or both. One such combination is the use of didanosine (ddI) with stavudine (d4T). Didanosine and stavudine are both nucleoside reverse transcriptase inhibitors (NRTIs) that work by inhibiting the replication of HIV. However, when used together, they can cause severe peripheral neuropathy, lactic acidosis, and pancreatitis due to their overlapping toxicities.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided, so we cannot evaluate it.
**Option B:** Other combinations, such as lamivudine (3TC) with tenofovir (TDF), are generally safe and well-tolerated.
**Option C:** The combination of efavirenz (EFV) with nevirapine (NVP) is not typically contraindicated; however, caution is advised when using these non-nucleoside reverse transcriptase inhibitors (NNRTIs) together.
**Clinical Pearl / High-Yield Fact**
When selecting an antiretroviral regimen, it is essential to consider potential drug interactions, adverse effects, and the development of resistance. Always refer to the latest treatment guidelines for the most up-to-date recommendations.
**Correct Answer:** Not Provided - Please provide the correct options.